...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Detailed examination of lymph nodes improves prognostication in colorectal cancer.
【24h】

Detailed examination of lymph nodes improves prognostication in colorectal cancer.

机译:淋巴结的详细检查可改善大肠癌的预后。

获取原文
获取原文并翻译 | 示例

摘要

Up to 30% of stage II patients with curatively resected colorectal cancer (CRC) will develop disease recurrence. We evaluated whether examination of lymph nodes by multilevel sectioning and immunohistochemical staining can improve prognostication. Lymph nodes (n = 780) from 36 CRC patients who had developed disease recurrence (cases) and 72 patients who showed no recurrence of disease for at least 5 years (controls) were analyzed. Sections of 4 levels at 200-microm interval were immunohistochemically stained for cytokeratin expression. The first level was analyzed by conventional and automated microscopy, and the 3 following levels were analyzed by automated microscopy for the presence of tumor cells. Overall, cases showed more micrometastases (3 patients) than controls (1 patient). Analysis of a second level led to the additional detection of 1 patient with micrometastases (case) and 1 patient with macrometastasis (case). Examining more levels only led to additional isolated tumor cells, which were equally divided between cases and controls. Likewise, automated microscopy resulted only in detection of additional isolated tumor cells when compared with conventional microscopy. In multivariate analysis, micrometastases [odds ratio (OR) 26.3, 95% confidence interval (CI) 1.9-364.8, p = 0.015], T4 stage (OR 4.8, 95% CI 1.4-16.7, p = 0.013) and number of lymph nodes (OR 0.9, 95% CI 0.8-1.0, p = 0.028) were independent predictors for disease recurrence. Lymph node analysis of 2 levels and immunohistochemical staining add to the detection of macrometastases and micrometastases in CRC. Micrometastases were found to be an independent predictor of disease recurrence. Isolated tumor cells were of no prognostic significance.
机译:根治性切除大肠癌(CRC)的II期患者中,多达30%会复发疾病。我们评估了通过多层切片和免疫组织化学染色检查淋巴结是否可以改善预后。分析了36例已复发疾病的CRC患者(病例)和72例至少5年未复发的患者的淋巴结(n = 780)(对照组)。免疫组织化学法以200微米间隔的4个水平切片对细胞角蛋白表达进行染色。第一级通过常规和自动显微镜法进行分析,随后的3级通过自动显微镜法分析肿瘤细胞的存在。总体而言,病例(3例)比对照组(1例)显示出更多的微转移。对第二个水平的分析导致另外发现了1例有微转移的患者(病例)和1例有大转移的患者(病例)。检查更多的水平只会导致额外的分离出的肿瘤细胞,在病例和对照组之间均分。同样,与常规显微镜相比,自动显微镜仅能检测到其他分离的肿瘤细胞。在多变量分析中,微转移[赔率(OR)26.3、95%置信区间(CI)1.9-364.8,p = 0.015],T4期(OR 4.8、95%CI 1.4-16.7,p = 0.013)和淋巴结数目淋巴结转移(OR 0.9,95%CI 0.8-1.0,p = 0.028)是疾病复发的独立预测因子。 2个水平的淋巴结分析和免疫组织化学染色增加了对CRC中大转移和微小转移的检测。发现微转移是疾病复发的独立预测因子。分离的肿瘤细胞无预后意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号